Halozyme Therapeutics PE Ratio 2010-2024 | HALO

Halozyme Therapeutics PE ratio as of November 14, 2024 is 17.13.

Current and historical p/e ratio for Halozyme Therapeutics (HALO) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Halozyme Therapeutics PE Ratio 2010-2024 | HALO

Current and historical p/e ratio for Halozyme Therapeutics (HALO) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.